Former FDA chief Gottlieb says remdesivir still provides treatment benefit for hospitalized Covid-19 patients

A WHO panel advised doctors against using Gilead Sciences' antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins "Squawk Box" to give his thoughts on the decision.
Fri, Nov 20 20209:02 AM EST